Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway

References

• Abse W. D., Dahlstrøm. The value of chemotherapy in senile mental disturbances. J.A.M.A 1960; 174: 2036–20421. Abse W. D., Dahlstrøm. The value of chemotherapy in senile mental disturbances. J.A.M.A 1960; 174: 2036–2042
   PubMed Web of Science ®Google Scholar
• Ahlfors U. G., Dencker S. J., Gravem A., Remvig J. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial. Acta Psychiatr. Scand. 1990; 279: 77–912. Ahlfors U. G., Dencker S. J., Gravem A., Remvig J. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial. Acta Psychiatr. Scand. 1990; 279: 77–91
   Google Scholar
• Bang Olsen R., Gydesen S. V., Kristensen M., Eschen F. T., Sorensen C., Hasle H., Lund S., Baastrup P. C., Gylding-Sabroe J. Psychotropic medication in the elderly. Dan. Med. Bull. 1990; 37: 455–4593. Bang Olsen R., Gydesen S. V., Kristensen M., Eschen F. T., Sorensen C., Hasle H., Lund S., Baastrup P. C., Gylding-Sabroe J. Psychotropic medication in the elderly. Dan. Med. Bull. 1990; 37: 455–459
   PubMed Web of Science ®Google Scholar
• Barnes R., Veith R., Okimoto J., Baskind M., Gumbrecht G. Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am. J. Psychiaty 1982; 139: 1170–11744. Barnes R., Veith R., Okimoto J., Baskind M., Gumbrecht G. Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am. J. Psychiaty 1982; 139: 1170–1174
   PubMed Web of Science ®Google Scholar
• Beardsley R. S., Larson D. B., Burns B. J., Thompson J. W., Kamerow D. B. Prescribing of psychotropics in elderly nursing home patients. J. Am. Geriatr. Soc. 1989; 37: 327–3305. Beardsley R. S., Larson D. B., Burns B. J., Thompson J. W., Kamerow D. B. Prescribing of psychotropics in elderly nursing home patients. J. Am. Geriatr. Soc. 1989; 37: 327–330
   PubMed Web of Science ®Google Scholar
• Beers M., Avorn J., Soumerai S. B., Everitt D. E., Salem S. Psychoactive medication use in intermediate-care facility residents. J.A.M.A. 1988; 260: 3016–30206. Beers M., Avorn J., Soumerai S. B., Everitt D. E., Salem S. Psychoactive medication use in intermediate-care facility residents. J.A.M.A. 1988; 260: 3016–3020
   PubMed Web of Science ®Google Scholar
• Bergman U., Dahlström M., Gunnarsson C., Westerholm B. Why are psychotropic drugs prescribed to out-patients?. Eur J. Clin. Pharmacol. 1979; 15: 249–2567. Bergman U., Dahlström M., Gunnarsson C., Westerholm B. Why are psychotropic drugs prescribed to out-patients?. Eur J. Clin. Pharmacol. 1979; 15: 249–256
   PubMed Web of Science ®Google Scholar
• Dencker S. J. Zuklopentixolets preferens ved psykotisk fiendtlighed. Nord. Psykiatr. Tidsskr 1988; 42: 495–4968. Dencker S. J. Zuklopentixolets preferens ved psykotisk fiendtlighed. Nord. Psykiatr. Tidsskr 1988; 42: 495–496
   Google Scholar
• Fuglum E., Schillinger A., Andersen J. B., Belstad B. E., Jenssen D., Müller F., Müller K. J., Schulstad B., Elgen K. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. Pharmathevapeutica 1989; 5: 285–2919. Fuglum E., Schillinger A., Andersen J. B., Belstad B. E., Jenssen D., Müller F., Müller K. J., Schulstad B., Elgen K. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. Pharmathevapeutica 1989; 5: 285–291
   PubMedGoogle Scholar
• Gilleard C. J., Morgan K., Wade B. E. Patterns of neuroleptic use among the institutionalised elderly. Acta Psychiatr. Scand. 1983; 68: 419–42510. Gilleard C. J., Morgan K., Wade B. E. Patterns of neuroleptic use among the institutionalised elderly. Acta Psychiatr. Scand. 1983; 68: 419–425
   PubMed Web of Science ®Google Scholar
• Götestam S. E., Ljunghall S., Olsson B. A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia. Acta Psychiatr. Scand. 1981; 294: 46–5311. Götestam S. E., Ljunghall S., Olsson B. A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia. Acta Psychiatr. Scand. 1981; 294: 46–53
   Google Scholar
• Gottfries C. G., Bråne G., Steen G. A new rating scale for dementia syndromes. Gevontology 1982; 28: 20–31, Suppl. 212. Gottfries C. G., Bråne G., Steen G. A new rating scale for dementia syndromes. Gevontology 1982; 28: 20–31, Suppl. 2
   PubMed Web of Science ®Google Scholar
• Knutsen A. T. Psykofarmaka og eldre. Tidsskr Nor: Lœgeforen. 1987; 107: 821–82213. Knutsen A. T. Psykofarmaka og eldre. Tidsskr Nor: Lœgeforen. 1987; 107: 821–822
   PubMedGoogle Scholar
• Lingjærde O., Ahlfors U. G., Bech P., Dencker S. J., Elgen K. The UKU side effect rating scale. Acta Psychiatc Scand. 1987; 76: 81–94, Suppl. 33414. Lingjærde O., Ahlfors U. G., Bech P., Dencker S. J., Elgen K. The UKU side effect rating scale. Acta Psychiatc Scand. 1987; 76: 81–94, Suppl. 334
   Google Scholar
• Nygaard H. A., Bakke K. J., Brudvik E., Lien G. K., Moe T. J., Elgen K. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study. Pharmatherapeutica 1987; 5: 152–15815. Nygaard H. A., Bakke K. J., Brudvik E., Lien G. K., Moe T. J., Elgen K. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study. Pharmatherapeutica 1987; 5: 152–158
   Google Scholar
• Nygaard H. A., Bakke K. J., Breivik K. Mental and physical capacity and consumption of neuroleptic drugs in residents of homes for aged people. Acta Psychiatr Scand. 1989; 80: 170–17316. Nygaard H. A., Bakke K. J., Breivik K. Mental and physical capacity and consumption of neuroleptic drugs in residents of homes for aged people. Acta Psychiatr Scand. 1989; 80: 170–173
   PubMed Web of Science ®Google Scholar
• Nygaard H. A., Bakke K. J., Breivik K., Brudvik E. Mental and physical capacity and consumption of neuroleptic drugs in residents of nursing homes. Int. J. Geriatr Psychiatry 1990; 5: 303–30817. Nygaard H. A., Bakke K. J., Breivik K., Brudvik E. Mental and physical capacity and consumption of neuroleptic drugs in residents of nursing homes. Int. J. Geriatr Psychiatry 1990; 5: 303–308
   Web of Science ®Google Scholar
• Rise S. C., Barnes R. Pharmacologic treatment of agitation associated with dementia. J. Am. Geriatr. Soc. 1986; 34: 368–37618. Rise S. C., Barnes R. Pharmacologic treatment of agitation associated with dementia. J. Am. Geriatr. Soc. 1986; 34: 368–376
   PubMed Web of Science ®Google Scholar
• Sachs H. S., Berrier J., Reitman D., Ancona-Ber V. A., Chalmers T. C. Meta-analysis of randomised controlled trials. N. Engl. J. Med. 1987; 316: 450–45519. Sachs H. S., Berrier J., Reitman D., Ancona-Ber V. A., Chalmers T. C. Meta-analysis of randomised controlled trials. N. Engl. J. Med. 1987; 316: 450–455
   PubMedGoogle Scholar
• Schneider L. S., Pollock V. E., Lyness S. A. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J. Am. Geriatr. Soc. 1990; 38: 553–56320. Schneider L. S., Pollock V. E., Lyness S. A. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J. Am. Geriatr. Soc. 1990; 38: 553–563
   PubMed Web of Science ®Google Scholar
• Smith G. R., Taylor C. W., Linkous P. Haloperidol versus thioridazine for treatment of psychogeriatric patients: a double-blind clinical trial. Psychosomatics 1974; 15: 134–13821. Smith G. R., Taylor C. W., Linkous P. Haloperidol versus thioridazine for treatment of psychogeriatric patients: a double-blind clinical trial. Psychosomatics 1974; 15: 134–138
   Web of Science ®Google Scholar
• Tellnes G., Bjørndal A., Fugelli P. Psychotropic drug-users and non-users in general practice. II. A three-year retrospective study from an island community in Northern Norway. Scand. J. Prim. Health Cure 1986; 4: 137–14122. Tellnes G., Bjørndal A., Fugelli P. Psychotropic drug-users and non-users in general practice. II. A three-year retrospective study from an island community in Northern Norway. Scand. J. Prim. Health Cure 1986; 4: 137–141
   PubMedGoogle Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. “ATC Index including DDDs for Plain Substances.”. WHO, Oslo 199023. WHO Collaborating Centre for Drug Statistics Methodology. “ATC Index including DDDs for Plain Substances.”. WHO, Oslo 1990
   Google Scholar